Nature escapes in a headset: a new way to calm cancer infusions?
NCT ID NCT07755501
First seen Aug 10, 2026 · Last updated Aug 13, 2026 · Updated 3 times
Summary
This randomized trial tests whether immersive virtual reality (VR) can reduce anxiety in people with lung cancer during immunotherapy or chemo-immunotherapy infusions. Half of the 60 participants will use a VR headset showing calming nature scenes during four infusion visits, while the other half receives standard care. The study measures anxiety levels at week 9 and also looks at effects on tumor response, fatigue, pain, and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Immersive virtual reality using a Meta Quest 3S headset with 360-degree nature scenes
- What this could lead to
- If it works, virtual reality could become a simple, drug-free way to ease anxiety during cancer infusions, improving the treatment experience for many patients.
- What could go wrong
- This is a small, early-stage trial, and the benefit may be modest or not generalizable. Some participants might experience cybersickness or discomfort from the headset.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Giovanni Paolo II Hospital, Medical Oncology Unit, ASL Gallura
Olbia, Sardinia, 07026, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Your Tumor's DNA might predict immunotherapy success
- Can a new PET tracer light up hidden cancers?
- Fellow veterans may hold the key to earlier lung cancer detection